HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Unson, C. G. Articles by Merrifield, R. B. Search for Related Content PubMed PubMed Citation Articles by Unson, C. G. Articles by Merrifield, R. B. Social Bookmarking                      What's this?

J. Biol. Chem., Vol. 269, Issue 17, 12548-12551, Apr, 1994

Multiple-site replacement analogs of glucagon. A molecular basis for antagonist design

CG Unson, CR Wu, KJ Fitzpatrick and RB Merrifield
Rockefeller University, New York, New York 10021.

Extensive structure activity analysis has allowed us to identify specific residues in the glucagon sequence that are responsible for either receptor recognition or signal transduction. For instance, we have demonstrated that aspartic acid 9 and histidine 1 are essential for activation, and that an ionic interaction between the negative carboxylate and the protonated imidazole may contribute to the activation reaction at the molecular level. In the absence of the carboxylic group at position 9, aspartic 21 or aspartic 15 might furnish distal electrostatic effects to maintain partial agonism. Further investigation established that each of the 4 serine residues in the hormone play distinct roles. Serine 8 provides an important determinant of binding. Whereas neither serines 2, 11, nor 16 are required for receptor recognition. We have shown that serine 16 is essential for signal transduction and thus have identified it to be the third residue in glucagon to participate in a putative catalytic triad together with aspartic 9 and histidine 1, in the transduction of the glucagon response. In this work, we utilized insights into the functional significance of particular residues in the peptide appropriated from our structure-function assignments, as the basis of a molecular approach for the design of active-site directed antagonists of glucagon. The importance as well as the accuracy of our findings are confirmed by the synthesis of a series of improved glucagon antagonists based on replacements at positions 1, 9, 11, 16, and 21. The inhibition index, (I/A)50, of our best antagonist des-His1-[Nle9-Ala11- Ala16]glucagon amide, has been improved 10-fold over the previous best glucagon inhibitor.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				C. Q. Pan, J. M. Buxton, S. L. Yung, I. Tom, L. Yang, H. Chen, M. MacDougall, A. Bell, T. H. Claus, K. B. Clairmont, et al. Design of a Long Acting Peptide Functioning as Both a Glucagon-like Peptide-1 Receptor Agonist and a Glucagon Receptor Antagonist J. Biol. Chem., May 5, 2006; 281(18): 12506 - 12515. [Abstract] [Full Text] [PDF]

				B. K. C. Chow, T. W. Moon, R. L. C. Hoo, C.-M. Yeung, M. Muller, P. J. Christos, and S. Mojsov Identification and Characterization of a Glucagon Receptor from the Goldfish Carassius auratus: Implications for the Evolution of the Ligand Specificity of Glucagon Receptors in Vertebrates Endocrinology, July 1, 2004; 145(7): 3273 - 3288. [Abstract] [Full Text] [PDF]

				C. G. Unson, C.-R. Wu, C. P. Cheung, and R. B. Merrifield Positively Charged Residues at Positions 12, 17, and 18 of Glucagon Ensure Maximum Biological Potency J. Biol. Chem., April 24, 1998; 273(17): 10308 - 10312. [Abstract] [Full Text] [PDF]

				C. Montrose-Rafizadeh, H. Yang, B. D. Rodgers, A. Beday, L. A. Pritchette, and J. Eng High Potency Antagonists of the Pancreatic Glucagon-like Peptide-1 Receptor J. Biol. Chem., August 22, 1997; 272(34): 21201 - 21206. [Abstract] [Full Text] [PDF]

				C. G. Unson, C.-R. Wu, T. P. Sakmar, and R. B. Merrifield Selective Stabilization of the High Affinity Binding Conformation of Glucagon Receptor by the Long Splice Variant of Galpha s J. Biol. Chem., July 7, 2000; 275(28): 21631 - 21638. [Abstract] [Full Text] [PDF]

				P. Nicole, L. Lins, C. Rouyer-Fessard, C. Drouot, P. Fulcrand, A. Thomas, A. Couvineau, J. Martinez, R. Brasseur, and M. Laburthe Identification of Key Residues for Interaction of Vasoactive Intestinal Peptide with Human VPAC1 and VPAC2 Receptors and Development of a Highly Selective VPAC1 Receptor Agonist. ALANINE SCANNING AND MOLECULAR MODELING OF THE PEPTIDE J. Biol. Chem., July 28, 2000; 275(31): 24003 - 24012. [Abstract] [Full Text] [PDF]